International Journal of Stem Cells : eISSN 2005-5447

Table. 2.

Table. 2.

Clinical characteristics and experimental information for AML patients

Patient Fig. 2B Fig. 2C Age Sex WBC count [109/l] Cytogenetic anomalies
1 BM 21 F 4.45 46,XX,t(8;21)(q22;q22)[20]
2 BM 68 F 14.29 46,XX,i(14)(q10)[17]/49,idem,+8+9+21[3]
3 BM 67 F 3.39 46,XX[20]
4 BM 75 F 1.75 47,XX,+8[20]
5 BM 59 M 158.98 46,XY[20]
6 BM PB 44 M 233.51 46,XY,dup(1)(p22p34.3),del(5)(q31),t(10;11)(q22;q23)[18]/46,XY[2]
7 BM 55 F 6.46 45,X,-X,t(8;21)(q22;q22)[20]
8 BM 45 F 57.37 46,XX,t(8;21)(q22;q22)[8]/45,idem,-X[17]/46,XX[5]
9 BM 38 F 11.22 46,XX[20]
10 BM 71 F 2.68 46,XX[20]
11 BM 55 M 143.31 47,XY,+8[20]
12 BM 51 F 3.57 46,XX[20]
13 BM 85 M 22.67 46,XY,add(4)(p15),-16[9]/45,idem,add(11)(q23)[4]/45,Y,t(X;4;3) (p22.1;q25;p21)[5]/46,XY[2]
14 PB 43 M 103.41 46,XY,+1+der(1;22)(q10;q10)[3]/46,idem,t(6;12)(p21.1;p13) [16]/46,XY[1]
15 PB 33 F 9.28 46,XX[20]
16 PB 30 F 310.5 46,XX[20]
17 PB 57 M 274.08 46,XY[8]
18 PB 40 F 132.48 46,XX[20]
19 PB 68 M 148.24 46,XY[20]
20 PB 46 F 46.01 46,XX[20]
21 PB 67 F 4.46 46,XX,t(15;17)(q24;q21)[11]/46,idem,inv(6)(p11;2q21),r(11) (p15;q25)[4]/46,idem,r(6)(p24;q13)[3]/46,XX[2]
22 PB 40 M 345.96 46,XY,t(9;22)(q34;q11.2)[3]/46,sl,t(1;3)(p22;q27)[11]/47,sdl1, +der(22)t(9;22)[2]/53,sdl2,+4,+8,+10,+21[cp4]
23 PB 48 F 137.18 46,XX,del(6)(q13;q16)[4]/46,XX[16]
International Journal of Stem Cells 2021;14:400-9 https://doi.org/10.15283/ijsc21083
© 2021 International Journal of Stem Cells